CoChat
Sign Up
Cited by 1,130Blood Pressure and Hypertension StudiesRenin-Angiotensin System StudiesSodium Intake and Health

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly

Open access
Wing, Lindon M.H., Reid, Christopher M., Ryan, Philip, Beilin, Lawrence J., Brown, Mark A., Jennings, Garry L.R., Johnston, Colin I., McNeil, John J., Macdonald, Graham J., Marley, John E., Morgan, Trefor O., West, Malcolm J.·2003·New England Journal of Medicine
DOI 10.1056/nejmoa021716
Open this paper in CoChat — free account

Abstract

BACKGROUND: Treatment of hypertension with diuretics, beta-blockers, or both leads to improved outcomes. It has been postulated that agents that inhibit the renin-angiotensin system confer benefit beyond the reduction of blood pressure alone. We compared the outcomes in older subjects with hypertension who were treated with angiotensin-converting-enzyme (ACE) inhibitors with the outcomes in those treated with diuretic agents. METHODS: We conducted a prospective, randomized, open-label study with blinded assessment of end points in 6083 subjects with hypertension who were 65 to 84 years of age and received health care at 1594 family practices. Subjects were followed for a median of 4.1 years, and the total numbers of cardiovascular events in the two treatment groups were compared with the use of multivariate proportional-hazards models. RESULTS: At base line, the treatment groups were well matched in terms of age, sex, and blood pressure. By the end of the study, blood pressure had decreased to a similar extent in both groups (a decrease of 26/12 mm Hg). There were 695 cardiovascular events or deaths from any cause in the ACE-inhibitor group (56.1 per 1000 patient-years) and 736 cardiovascular events or deaths from any cause in the diuretic group (59.8 per 1000 patient-years; the hazard ratio for a cardiovascular event or death with ACE-inhibitor treatment was 0.89 [95 percent confidence interval, 0.79 to 1.00]; P=0.05). Among male subjects, the hazard ratio was 0.83 (95 percent confidence interval, 0.71 to 0.97; P=0.02); among female subjects, the hazard ratio was 1.00 (95 percent confidence interval, 0.83 to 1.21; P=0.98); the P value for the interaction between sex and treatment-group assignment was 0.15. The rates of nonfatal cardiovascular events and myocardial infarctions decreased with ACE-inhibitor treatment, whereas a similar number of strokes occurred in each group (although there were more fatal strokes in the ACE-inhibitor group). CONCLUSIONS: Initiation of antihypertensive treatment involving ACE inhibitors in older subjects, particularly men, appears to lead to better outcomes than treatment with diuretic agents, despite similar reductions of blood pressure.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa021716

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Flagged first, then by citations

Show all 44 references

Research works printed but not linked: 5

  1. 1980, Lancet, 1, 1261
  2. 10.1001/jama.265.24.3255 · DOI · Paper page
  3. 1990, Bull Pan Am Health Organ, 24, 606
  4. 1999, J Hypertens, 17, 151
  5. 1998, J Hypertens, 16, 127

Cited by

Sorted by citations

Items 401–500 of 1,000

Related

See all

Metadata

Authors
Wing, L. M. H., Reid, C. M., Ryan, P., Beilin, L. J., Brown, M. A., Jennings, G. L. R., Johnston, C. I., McNeil, J. J., Macdonald, G. J., Marley, J. E., Morgan, T. O., & West, M. J.
Affiliations
  • Flinders University (AU)
  • The University of Adelaide (AU)
  • The University of Western Australia (AU)
  • UNSW Sydney (AU)
  • Monash University (AU)
  • MSD (Australia) (AU)
  • Newcastle University (GB)
  • The University of Melbourne (AU)
  • The University of Queensland (AU)
ORCID
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
2003-02-13
Volume
348
Issue
7
Pages
583-592
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
DOI
10.1056/nejmoa021716
OpenAlex
W2146851676
Cited by
1,130
References
44
Citations by year
2026: 8 · 2025: 10 · 2024: 12 · 2023: 13 · 2022: 11 · 2021: 21 · 2020: 11 · 2019: 17 · 2018: 31 · 2017: 28 · 2016: 29 · 2015: 37 · 2014: 39 · 2013: 42 · 2012: 54
FWCI
98.38
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • eCite Digital Repository (University of Tasmania) (submittedVersion)
  • Bond University Research Portal (Bond University) (submittedVersion, other-oa)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • Flinders Academic Commons (Flinders University) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • ANU Open Research (Australian National University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords
hypertension, older adults, ACE inhibitors, diuretics, renin-angiotensin system, cardiovascular events, mortality, myocardial infarction, stroke, sex differences, family medicine patients, blood pressure reduction, beta-blockers, cardiovascular risk reduction, cardiovascular risk stratification
MeSH terms
Aged, Aged, 80 and over, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Diuretics, Drug Therapy, Combination, Female, Humans, Hypertension, Male, Prospective Studies, Sex Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review